News

• NICE publishes first three quality standards
• Published on Jul 19, 2010

NICE has defined high-quality care for the NHS in three areas with its first set of quality standards.

• Testosterone increases CV risk in older men
• Published on Jul 19, 2010

A trial of topical testosterone to increase muscle strength in older men has been discontinued because it increased the risk of cardiovascular effects (NEJM 2010; doi: 10.1056/NEJMoa 1000485).

• Intensive treatment for T2D slows retinopathy
• Published on Jul 19, 2010

Intensive glycaemic and lipid control slows the rate of retinopathy progression in patients with type 2 diabetes by about one-third, according to an analysis of the ACCORD trial (NEJM 2010; doi: 10.1056/NEJMoa 1001288).

• Sativex approved for MS
• Published on Jul 19, 2010

The cannabinoid Sativex is now available for the treatment of spasticity unresponsive to other treatments in patients with multiple sclerosis.

• Levitra matches Viagra
• Published on Jul 19, 2010

Bayer Schering Pharma has cut the price of its erectile dysfunction drug vardenafil (Levitra).